VUMC research aids approval of Covid vaccine for young children

by Bill Snyder

The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old as early as tomorrow, following the unanimous recommendation by an FDA advisory panel on Wednesday.

Pending approval by an advisory panel of the U.S. Centers for Disease Control and Prevention, which is scheduled to meet this weekend, states including Tennessee that already have ordered millions of doses could begin distributing the vaccine to health care providers as early as next week, White House officials said.

“Many parents of very young children have struggled to navigate the pandemic without a vaccine available for their children,” said C. Buddy Creech, MD, MPH., director of the Vanderbilt Vaccine Research Program and the Edie Carell Johnson Professor of Pediatrics at Vanderbilt University Medical Center.

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.